Azitra Inc (AZTR)
AZTR trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.0715
-39.20% on the day
Market cap
$4.3M
Nano cap
Revenue · 2025
$0
-100.0% on 2024
Net income · 2025
-$11.0M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AZTR on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Not reported by the screener |
| IPO year | 2023 |
| SEC CIK | 0001701478 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$11.0M |
| Operating income | -$11.0M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | -100.0% |
| Cash | $2.1M |
| Total assets | $5.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-28 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-10-01 |
| Latest proxy | DEFA14A | 2026-06-04 |
Source: SEC EDGAR submissions feed, 234 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NCNA | NuCana plc American Depositary Share | $1.05 | -2.78% | $4.4M |
| PPCB | Propanc Biopharma Inc. | $0.4125 | -6.25% | $4.3M |
| DRMA | Dermata Therapeutics Inc. | $0.8599 | -3.34% | $4.3M |
| ENLV | Enlivex Ltd. | $0.2224 | -12.10% | $4.4M |
| JUNS | Jupiter Neurosciences Inc. | $3.36 | +10.53% | $4.4M |
| LNAI | Lunai Bioworks Inc. | $1.03 | -7.21% | $4.7M |
| XTLB | XTL Biopharmaceuticals Ltd. | $1.98 | +3.12% | $4.9M |
| XBIO | Xenetic Biosciences Inc. | $2.10 | -0.94% | $4.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier